ÖZLÜ, T. Et Al. 2015. Should Low-Molecular-Weight Heparin Be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism. ATS CONGRESS , (Denver, United States Of America), 1.

ÖZLÜ, T., YILMAZEL UÇAR, E., Senturk, A., Berk, S., Altinsoy, B., Dabak, ,., ... Cakır, E.(2015). Should Low-Molecular-Weight Heparin Be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism . ATS CONGRESS (pp.1). Denver, United States Of America

ÖZLÜ, TEVFİK Et Al. "Should Low-Molecular-Weight Heparin Be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism," ATS CONGRESS, Denver, United States Of America, 2015

ÖZLÜ, TEVFİK Et Al. "Should Low-Molecular-Weight Heparin Be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism." ATS CONGRESS , Denver, United States Of America, pp.1, 2015

ÖZLÜ, T. Et Al. (2015) . "Should Low-Molecular-Weight Heparin Be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism." ATS CONGRESS , Denver, United States Of America, p.1.

@conferencepaper{conferencepaper, author={TEVFİK ÖZLÜ Et Al. }, title={Should Low-Molecular-Weight Heparin Be Preferred Over Unfractionated Heparin After Thrombolysis for Severity Pulmonary Embolism}, congress name={ATS CONGRESS}, city={Denver}, country={United States Of America}, year={2015}, pages={1} }